The Latest Life Sciences Tools & Diagnostics Articles from Streetwise Reports


Nano-X Imaging Receives Go Ahead from FDA for Single Source Digital X-Ray

  ()
Shares of Nano-X Imaging Ltd. traded 17% higher after the company reported that the FDA has granted 510(k) approval for its single source ARC digital x-ray. read more >

RadNet Shares Rise 17% on Record Q4 Revenue and Bright Outlook for 2021

  ()
Shares of RadNet Inc. reached a new 52-week high after the diagnostic imaging company reported record revenue and adjusted EBITDA for Q4/21 and offered positive financial guidance for FY/21. read more >

FDA Grants Expanded Use in General Surgery for Asensus Surgical's Robotic Laparoscopic Platform

  ()
Asensus Surgical shares traded 16.5% higher after the company reported it received clearance from the U.S. Food & Drug Administration for its Senhance© Surgical System for use in general surgical procedures. read more >

Analyst: All Systems Are Go for Testing, Testing and More Testing

Research Report
  ()
This Dawson James report explains why ProPhase Labs is perfectly positioned to benefit from expanded COVID testing. read more >

Telehealth Tech Company Continues Rapid Growth in COVID-Changed Landscape

  ()
Reliq Health introduces iUGO Home services and just added a care management network in California with 50 clinics and over 500 physicians. read more >

Pacific Biosciences Shares Rise 22% on $900 Million Investment from Japan's SoftBank

  ()
Shares of Pacific Biosciences of California traded to a new 52-week high after the firm reported that a Softbank Group subsidiary will invest $900 million to support its growth initiatives. read more >

Align Technology Shares Grind 12.5% Higher after Firm Posts Record Q4 Revenue of $834.5 Million

  ()
Align Technology shares set a new 52-week high after the company announced financial results that included record FY/20 total revenues of $2.5 billion. read more >

Abiomed Shares Gain 8% After Firm Announces Record Q3 Revenue of $232 Million

  ()
Shares of cardiac medical device maker Abiomed Inc. traded higher after the company reported record revenue for Q3/21 despite the impact from COVID-19. read more >

A Solace to the Stress of the SolarWinds Hack

Contributed Opinion
  ()
Against the backdrop of the massive SolarWinds hack, value investor Jack Hurley discusses his investment thesis for Leonovus Inc, whose products provide an "ironclad level of cybersecurity." read more >

Imagin Medical Is Bringing Cystoscopy into the 21st Century

Contributed Opinion
  ()
Dr. KSS, MD, PhD, editor-in-chief of PubBio.co, profiles a small cap that "is poised to bring to clinic a next-generation of must-have cystoscopy equipment." read more >
News Update

Neurosciences Firm Outlines Strategic Priorities for 2021

News Update
  ()
ProMIS Neurosciences discusses its four priority areas in 2021. read more >

Avinger Shares Rise 40% on Launch of Image-Guided Device to Diagnose and Treat PAD

  ()
Shares of Avinger Inc. reached a new 52-week high after the company reported it initiated a full commercial launch of its TigereyeÖ Image-Guided CTO Crossing Catheter system for diagnosing and treating peripheral artery disease. read more >

This Tiny Digital Healthcare Company's Sales Should Rocket Higher

Contributed Opinion
  ()
Independent financial analyst Matt Badiali profiles a small cap whose blood glucose monitoring system works with any smartphone. read more >

This Tiny Tech Stock Is Quietly Building a Huge Business in Air Quality

Contributed Opinion
  ()
Independent financial analyst Matt Badiali discusses how mCloud's technology is making it possible for office buildings to reopen during the pandemic. read more >

California Biotech Advances Two COVID-19 Products

Research Report
  ()
Recent news concerning Sorrento Therapeutics' SARS-CoV-2 virus test and antibodies is discussed in a Dawson James Securities report. read more >

DermTech Shares Rise 32% on Geisinger Health Support for Skin Cancer Test

  ()
Shares of DermTech Inc. climbed to a new 52-week high after the company reported it has received positive medical coverage by Geisinger Health System for its pigmented lesion assay, a non-invasive test for detecting melanoma. read more >

BioTelemetry Shares Beat Higher on Royal Philips $2.8 Billion Buyout Offer

  ()
Shares of BioTelemetry Inc. rise 16.5% to a new 52-week high after Royal Philips agreed to acquire the company for US$2.8 billion, or US$72.00 per share in an all cash transaction. read more >

Biotech's Potentially Disruptive Diagnostics Platform on 'Cusp of Commercialization'

Research Report
  ()
Recent trial results, a timeline to the launch of Quotient's system and the reasons the debut should be successful are discussed in a Cowen report. read more >

Renalytix AI Shares Climb 30% on Q1 Earnings and EUA for JV's SARS-CoV-2 IgG Antibody Test Kit

  ()
Shares of Renalytix AI Plc. traded 30% higher after the company reported Q1/21 financial results and that its joint venture with Mt. Sinai Health System was granted Emergency Use Authorization by the FDA for its SARS-CoV-2 IgG antibody test kit. read more >
News Update

Biotech Involved in COVID-19, Neurodegenerative Diseases Reports Q3/20 Results

News Update
  ()
ProMIS Neurosciences formed two new joint ventures, one for developing tests for the detection, diagnosis and monitoring of Alzheimer's disease, and the second for serological assays for antibodies to the SARS-CoV-2 virus. read more >

Individuals Succeed Using This Digital TherapyŚNow It's Moving to Insurers

Contributed Opinion
  ()
Independent financial analyst Matt Badiali profiles a digital therapeutics company that is changing diabetes treatment. read more >

Inspire Medical's Shareholders Rest Comfortably on Q3 Earnings and Raised FY Outlook

  ()
Shares of Inspire Medical Systems traded 30% higher and set a new 52-week high after the company reported Q3/20 financial results that included a 72% rise in YoY revenue. read more >

Exact Sciences Shares Rise 29% as Firm Announces Q3 Earnings, a Capital Raise and Two Acquisitions

  ()
Exact Sciences Corp. shares reached a new 52-week high after the maker of cancer screening test Cologuard reported Q3/20 financial results that included a greater than 86% increase in year-over-year revenue. read more >
Showing Results: 1 to 23 of 23

Get Our Streetwise Reports Newsletter Free and be the first to know!

A valid email address is required to subscribe